DaVita (DVA) Misses Q3 EPS by 13c, Beats on Revenue
Get Alerts DVA Hot Sheet
Price: $182.17 -1.92%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
FUSE, INM, TRI, More
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q3 EPS of $2.59, $0.13 worse than the analyst estimate of $2.72. Revenue for the quarter came in at $3.26 billion versus the consensus estimate of $3.25 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Innospec (IOSP) Tops Q3 EPS by 2c
- LATAM Airlines (LTM) Misses Q3 EPS by 135c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share